U.S. Physical Therapy, Inc. - Q1 2005 Filing Summary
Business Context and Reporting Period
This Form 10-Q covers the quarterly period ended March 31, 2005. U.S. Physical Therapy, Inc. operates outpatient physical and occupational therapy clinics. As of the reporting date, the company operated 269 clinics across 36 states. The company primarily utilizes a "Traditional Partnership Model" where it holds a majority interest in clinic partnerships, though it also operates some wholly-owned facilities.
Key Financial Metrics
| Metric | Q1 2005 | Q1 2004 |
|---|---|---|
| Net Revenues | $30.9 million | $28.3 million |
| Net Income | $2.0 million | $1.5 million |
| Diluted EPS | $0.17 | $0.13 |
| Operating Cash Flow | $6.1 million | $3.2 million |
| Cash & Equivalents | $20.9 million | $18.4 million |
| Total Debt | $70,000 (Notes Payable) | $70,000 |
| Current Ratio | 5.3:1 | 7.2:1 (Dec 31, 2004) |
Margins: Clinic operating costs were 72.8% of net revenues in Q1 2005, down from 74.3% in Q1 2004. The effective tax rate was 37.6%.
Material Changes vs. Prior Period
- Revenue Growth: Net revenues increased 9.1% year-over-year, driven by an 8.1% increase in total patient visits (313,675 vs. 290,248) and a slight increase in revenue per visit ($96.76 vs. $95.49).
- Profitability: Net income rose 32.4% to $2.0 million. Operating income increased to $4.3 million from $3.7 million.
- Clinic Expansion: The company added six new clinics in Q1 2005. New clinics contributed approximately 73% of the total revenue increase.
- Cost Management: The provision for doubtful accounts decreased 21.4% to $312,000 due to improved collection efforts. Corporate office costs rose 11.5% primarily due to Sarbanes-Oxley compliance and personnel increases.
- Share Repurchases: The company repurchased 239,882 shares of common stock for $3.6 million during the quarter.
Outlook, Risks, and Management Commentary
- Guidance: Management expects to continue focusing on the Traditional Partnership Model and opening satellite clinics. They anticipate initial operating losses from new clinics opened in late 2004 and 2005.
- Liquidity: The company maintains $20.9 million in cash and equivalents, which management believes is sufficient to fund operations, development, and minority interest purchases through 2005 without external credit lines.
- Risks: Key risks include changes in Medicare reimbursement rates (specifically the $1,500 annual limit), regulatory compliance, and the availability of qualified therapists. The company notes that new clinics typically experience lower margins during their first year of operation.
- Accounting Changes: The company is preparing to adopt SFAS 123R (Share-Based Payment) effective January 1, 2006, which will require expensing stock options based on fair value rather than the current intrinsic value method.
Investor Verification Checklist
- Verify the sustainability of the 8.1% visit growth rate given the mix of new vs. mature clinics.
- Monitor the impact of the Medicare $1,500 therapy limit on future reimbursement rates and revenue per visit.
- Assess the cash burn rate associated with the $3.6 million in share repurchases and $1.2 million in minority interest distributions.
- Review the timeline for the adoption of SFAS 123R and its potential impact on future net income and EPS.
- Confirm the status of the $140,000 remaining accrual for lease obligations related to eight clinics closed in 2004.